Image For Activity Cover
The Lead Episode 32: Chlorhexidine Gluconate Pocket Lavage to Prevent Cardiac Implantable Electronic Device Infection in High-Risk Procedures
Description
Danesh Kella, MBBS, FHRS, and Christopher V. DeSimone, MD, PhD, FHRS, of Mayo Clinic are joined by guests Christopher J. McLeod, MBChB, PhD, FHRS, and Siva K. Mulpuru, MD, FHRS, of Mayo Clinic to discuss Chlorhexidine Gluconate Pocket Lavage to Prevent Cardiac Implantable Electronic Device Infection in High-Risk Procedures.
Learning Objectives
  • To understand the impact of cardiac implantable electronic device (CIED) infection in high-risk procedures
  • To understand the existing methods for CIED infection prevention and impact of Chlorhexidine gluconate pocket lavage to reduce the risk of CIED infection.
Article Authors and Podcast Contributors
Article Authors
Juan Carlos Diaz, MD, Eric D. Braunstein, MD, Felipe Cañas, MD, Mauricio Duque, MD, FHRS, Jorge Eduardo Marín, MD, Julian Aristizabal, MD, Cesar Daniel Niño, MD, Oriana Bastidas, MD, Carolina Hoyos, MD, Nathaniel Steiger, MD, Carlos D. Matos, MD, William H. Sauer, MD, FHRS, Jorge E. Romero, MD, FHRS

Podcast Contributors
Danesh Kella, MBBS, FHRS, of Mayo Clinic (Jacksonville)
Christopher V. DeSimone, MD, PhD, FHRS, of Mayo Clinic (Rochester)
Christopher J. McLeod, MBChB, PhD, FHRS, of Mayo Clinic (Jacksonville)
Siva K. Mulpuru, MD, FHRS, of Mayo Clinic (Rochester)

Disclosures

 

All relevant financial relationships have been mitigated.

Host Disclosure(s):
D. Kella: Honoraria/Speaking/Consulting Fee: Zoll Medical Company
C. DeSimone: No relevant financial relationships with ineligible companies to disclose. 

Contributor Disclosure(s):
C. McLeod: Honoraria/Speaking/Consulting Fee: BioSig Technologies
S. Mulpuru: No relevant financial relationships with ineligible companies to disclose. 


Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose. 
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By